Internal Medicine, Gastroenterology · Prospect Park, NJ
NPI
1093763039
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
160 Haledon Ave
Prospect Park, NJ, 07508
Phone (973) 782-4871
Groups this clinician bills Medicare through
Medicare paid, 2024
$195K
2,151 services
Medicare patients, 2024
351
Average age 73
Drug cost, 2024
$771K
2,996 prescriptions
Company payments, 2025
$1,976
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eyad Y Baghal was code 99232 (hospital e&m - subsequent), 987 times for 128 patients. In total Eyad Y Baghal billed 2,151 services in 42 codes, and Medicare paid $195K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 987 | 128 | $66.39 | $66K |
| 99233 Hospital E&M - Subsequent | Facility | 346 | 106 | $99.73 | $35K |
| 99213 Office E&M - Established | Office | 229 | 123 | $76.78 | $18K |
| 99223 Hospital E&M - Initial | Facility | 156 | 133 | $146.08 | $23K |
| 43239 Upper GI Endoscopy | Facility | 87 | 85 | $105.06 | $9,140 |
| 99204 Office E&M - New | Office | 57 | 57 | $136.08 | $7,756 |
| 99214 Office E&M - Established | Office | 50 | 39 | $111.03 | $5,551 |
| 45380 Lower GI Endoscopy - Other | Facility | 37 | 37 | $128.72 | $4,763 |
| 45385 Colonoscopy - Lesion Removal | Facility | 29 | 29 | $202.75 | $5,880 |
| 99306 SNF E&M | Office | 23 | 22 | $151.60 | $3,487 |
| 43246 Upper GI Endoscopy | Facility | 22 | 21 | $168.90 | $3,716 |
| 45378 Lower GI Endoscopy - Other | Facility | 22 | 22 | $143.57 | $3,159 |
| 99310 SNF E&M | Office | 14 | 11 | $130.54 | $1,828 |
| 99309 SNF E&M | Office | 13 | 11 | $91.72 | $1,192 |
By year: 2022 $242K for 2,684 services; 2023 $266K for 2,947 services; 2024 $195K for 2,151 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eyad Y Baghal prescribed most often to Medicare patients was Omeprazole, with 651 prescriptions and refills. In total Eyad Y Baghal wrote 2,996 Medicare prescriptions that cost $771K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 651 | 964 | 193 | $5,856 |
| Famotidine Generic | 274 | 410 | 87 | $2,932 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 242 | 242 | 232 | $3,484 |
| Pantoprazole Sodium Generic | 230 | 376 | 77 | $2,190 |
| Linzess Linaclotide | 201 | 293 | 57 | $150K |
| Dicyclomine Hcl Generic | 139 | 151 | 65 | $1,235 |
| Procto-Med Hc Hydrocortisone | 105 | 111 | 27 | $1,521 |
| Lactulose Generic | 89 | 97 | 30 | $3,600 |
| Hydrocortisone Generic | 76 | 89 | 37 | $1,885 |
| Sucralfate Generic | 67 | 83 | 27 | $3,918 |
| Ondansetron Hcl Generic | 66 | 66 | 31 | $743 |
| Trulance Plecanatide | 65 | 79 | 17 | $43K |
| Lansoprazole Generic | 64 | 96 | 31 | $1,282 |
| Metoclopramide Hcl Generic | 57 | 57 | 25 | $348 |
| Lubiprostone Generic | 52 | 85 | 17 | $6,098 |
Brand drugs: 543 claims; generic drugs: 2,453 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eyad Y Baghal $1,976 ($1,976 in general payments such as food, travel and fees) from 9 companies. The largest payer was Madrigal Pharmaceuticals with $859.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 13 | $859 |
| Amgen Inc. AMGN | 3 | $350 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $250 |
| Abbvie Inc. ABBV | 6 | $169 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $150 |
| Corcept Therapeutics CORT | 1 | $143 |
| Novo Nordisk Inc NVO | 1 | $23.69 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $16.08 |
| Aimmune Therapeutics, Inc. | 1 | $15.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.